SK2942003A3 - Chromenone derivatives and their use for treating diseases in conjunction with 5-HTA1 receptors and/or dopamine D2 receptors - Google Patents

Chromenone derivatives and their use for treating diseases in conjunction with 5-HTA1 receptors and/or dopamine D2 receptors Download PDF

Info

Publication number
SK2942003A3
SK2942003A3 SK294-2003A SK2942003A SK2942003A3 SK 2942003 A3 SK2942003 A3 SK 2942003A3 SK 2942003 A SK2942003 A SK 2942003A SK 2942003 A3 SK2942003 A3 SK 2942003A3
Authority
SK
Slovakia
Prior art keywords
formula
treatment
chromenone derivative
acceptable salts
physiologically acceptable
Prior art date
Application number
SK294-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Rudolf Gottschlich
Karl-August Ackermann
Helmut Prucher
Christoph Seyfried
Gert Bartoszyk
Amsterdam Christoph Van
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SK2942003A3 publication Critical patent/SK2942003A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK294-2003A 2000-08-24 2001-07-24 Chromenone derivatives and their use for treating diseases in conjunction with 5-HTA1 receptors and/or dopamine D2 receptors SK2942003A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10041574A DE10041574A1 (de) 2000-08-24 2000-08-24 Chromenonderivate
PCT/EP2001/008528 WO2002016354A1 (de) 2000-08-24 2001-07-24 Chromenonderivate und ihre verwendung zur behandlung von krankheiten im zusammenhang mit 5-hta1-rezeptoren und/oder dopamin-d2-rezeptoren

Publications (1)

Publication Number Publication Date
SK2942003A3 true SK2942003A3 (en) 2003-09-11

Family

ID=7653636

Family Applications (1)

Application Number Title Priority Date Filing Date
SK294-2003A SK2942003A3 (en) 2000-08-24 2001-07-24 Chromenone derivatives and their use for treating diseases in conjunction with 5-HTA1 receptors and/or dopamine D2 receptors

Country Status (16)

Country Link
US (1) US20040014768A1 (zh)
EP (1) EP1311503A1 (zh)
JP (1) JP2004506733A (zh)
KR (1) KR20030022390A (zh)
CN (1) CN1447807A (zh)
AU (1) AU2001289735A1 (zh)
BR (1) BR0113364A (zh)
CA (1) CA2420206A1 (zh)
CZ (1) CZ2003659A3 (zh)
DE (1) DE10041574A1 (zh)
MX (1) MXPA03001609A (zh)
NO (1) NO20030811D0 (zh)
PL (1) PL359222A1 (zh)
SK (1) SK2942003A3 (zh)
WO (1) WO2002016354A1 (zh)
ZA (1) ZA200302255B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1408976B3 (en) 2001-07-20 2010-08-25 Psychogenics Inc. Treatment for attention-deficit hyperactivity disorder
DE10217006A1 (de) * 2002-04-16 2003-11-06 Merck Patent Gmbh Substituierte Indole
US7160888B2 (en) 2003-08-22 2007-01-09 Warner Lambert Company Llc [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
EP1730730B1 (en) 2004-03-26 2009-11-25 LG Electronics, Inc. Recording medium and method and apparatus for reproducing text subtitle stream recorded on the recording medium
DE602005023285D1 (de) 2004-03-26 2010-10-14 Lg Electronics Inc Speichermedium,verfahren, und gerät zum wiedergeben von untertiteldatenströmen
WO2012087229A1 (en) * 2010-12-20 2012-06-28 Astrazeneca Ab 2-carboxamide-4-piperazinyl-benzofuran derivative
CN104059046B (zh) * 2013-03-18 2017-02-08 江苏恩华药业股份有限公司 黄酮类衍生物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704390A (en) * 1986-02-13 1987-11-03 Warner-Lambert Company Phenyl and heterocyclic tetrahydropyridyl alkoxy-benzheterocyclic compounds as antipsychotic agents
DE4111861A1 (de) * 1991-04-11 1992-10-15 Schwabe Willmar Gmbh & Co Benzopyranone, verfahren zu ihrer herstellung und verwendung

Also Published As

Publication number Publication date
AU2001289735A1 (en) 2002-03-04
BR0113364A (pt) 2003-07-15
JP2004506733A (ja) 2004-03-04
US20040014768A1 (en) 2004-01-22
NO20030811L (no) 2003-02-21
WO2002016354A1 (de) 2002-02-28
DE10041574A1 (de) 2002-03-07
CN1447807A (zh) 2003-10-08
CZ2003659A3 (cs) 2003-06-18
MXPA03001609A (es) 2003-06-04
KR20030022390A (ko) 2003-03-15
CA2420206A1 (en) 2003-02-21
PL359222A1 (en) 2004-08-23
NO20030811D0 (no) 2003-02-21
EP1311503A1 (de) 2003-05-21
ZA200302255B (en) 2004-08-16

Similar Documents

Publication Publication Date Title
US11807648B2 (en) Process for preparing substituted polycyclic pyridone derivative and crystal thereof
US10988456B2 (en) O-aminoheteroaryl alkynyl-containing compound, preparation method therefor, and use thereof
JP6800872B2 (ja) リシルオキシダーゼ様２阻害剤とその使用
JP4065034B2 (ja) ピペリジン類およびピペラジン類
TWI722004B (zh) 1,3,5-三嗪衍生物及其使用方法
TWI568728B (zh) 雜環化合物及彼之用途
US20190152932A1 (en) Indoleamine-2,3-dioxygenase inhibitor and preparation method therefor
CZ289449B6 (cs) 3-[4-(4-(4-Kyanfenyl)-1-piperazinyl)butyl]-5-kyanindol, způsob jeho přípravy a farmaceutický prostředek, který ho obsahuje
SK50895A3 (en) 3-indolylpiperidine derivative, method of its preparation, its use for preparation of pharmaceutical composition and pharmaceutical composition containing them
KR101710740B1 (ko) 2-［［［2-［(히드록시아세틸)아미노］-4-피리디닐］메틸］티오］-ｎ-［4-(트리플루오로메톡시)페닐］-3-피리딘카르복사미드의 벤젠술폰산염, 이의 결정, 이의 결정 다형 및 이들의 제조 방법
JP6719451B2 (ja) キナゾリン誘導体
SK2942003A3 (en) Chromenone derivatives and their use for treating diseases in conjunction with 5-HTA1 receptors and/or dopamine D2 receptors
US7425574B2 (en) Benzofuran oxyethylamines as antidepressants and anxiolytics
CZ2003809A3 (cs) Derivát arylpiperazinu, způsob jeho přípravy, jeho použití jako psychofarmaka a farmaceutický prostředek, který ho obsahuje
JP2006527707A (ja) セロトニン再取り込み阻害剤としてのインドール誘導体
SK17122002A3 (sk) Derivát heterocyklického aminoalkylpyridínu ako psychofarmaceutické činidlo, spôsob jeho prípravy, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje
AU2017300841A1 (en) Imidazolyl-substituted indole derivatives binding 5-HT7 serotonin receptor and pharmaceutical compositions thereof
JP7144863B2 (ja) イソキノリン化合物、その調製の方法、およびベータガラクトシダーゼの活性の変質に伴う状態におけるその治療的使用
US20230406854A1 (en) Covalent kras-binding compounds for therapeutic purposes
CZ327494A3 (en) Esters of nicotinic acid and process for preparing thereof
CN107304180B (zh) 苯甲酰胺类衍生物、其制备方法及其在医药上的用途
MXPA05008437A (es) Derivados de benzofurano y el uso de los mismos como antidepresivos y ansioliticos.
TW202419451A (zh) 一種二噁烷並喹啉類化合物的鹽、其晶型以及它們的製備方法及用途
CN116891465A (zh) 一类n-取代的喹啉酮化合物、其制备方法和用途
WO2023010354A1 (zh) 一种具有egfr抑制活性的小分子化合物及其制备方法与应用